Sunesis Pharmaceuticals to Present at the Bear Stearns 19th Annual Healthcare Conference
September 07 2006 - 9:30AM
PR Newswire (US)
SOUTH SAN FRANCISCO, Calif., Sept. 7 /PRNewswire-FirstCall/ --
Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) today announced that
Daniel N. Swisher, Jr., Chief Executive Officer and President, will
present a corporate update at the Bear Stearns 19th Annual
Healthcare Conference on Tuesday September 12, 2006 at 11:00 a.m.
ET at the Grand Hyatt in New York, NY. Interested parties may
access a webcast of the presentation by visiting the Sunesis
website at http://ir.sunesis.com/ . A replay of the webcast will be
archived on the "Calendar of Events" page in the Investors and
Media section of the Sunesis website for two weeks until September
26, 2006. About Sunesis Pharmaceuticals Sunesis is a clinical-stage
biopharmaceutical company focused on the discovery, development and
commercialization of novel small molecule therapeutics for oncology
and other serious diseases. Sunesis has built a broad product
candidate portfolio through internal discovery and in-licensing of
novel cancer therapeutics. Sunesis is advancing its product
candidates through in-house research and development efforts and
strategic collaborations with leading pharmaceutical and
biopharmaceutical companies. For additional information on Sunesis
Pharmaceuticals, please visit http://www.sunesis.com/ .
Forward-Looking Statements This press release may contain
forward-looking statements that involve substantial risks and
uncertainties. Sunesis may not actually achieve the plans,
intentions or expectations contained in such forward-looking
statements. Actual results or events could differ materially from
the plans, intentions and expectations contained in such
forward-looking statements. Sunesis does not assume any obligation
to update any such forward-looking statements. DATASOURCE: Sunesis
Pharmaceuticals, Inc. CONTACT: Investors, Eric Bjerkholt, CFO of
Sunesis Pharmaceuticals, Inc., +1-650-266-3717; or Media, Karen L.
Bergman, +1-650-575-1509, or Michelle Corral, +1-415-794-8662, both
of BCC Partners, for Sunesis Pharmaceuticals, Inc. Web site:
http://www.sunesis.com/
Copyright
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Sunesis Pharmaceuticals (NASDAQ:SNSS)
Historical Stock Chart
From Jul 2023 to Jul 2024